Summary of Classification and Labelling
General Information
EC / List no.
|
Name |
CAS Number
|
|---|---|---|
| 600-270-5 | 5-[3-[(1S)-2-(difluoromethoxy)-1-methylethoxy]-5-[[(5-methyl-2-pyrazinyl)amino]carbonyl]phenoxy]-N,N-dimethyl- 2-pyrazinecarboxamide | 1020668-59-0 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives
|
Additional Notified Information
|
Number of Notifiers
|
Joint Entries
|
||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Acute Tox. 4 | H302 | H302 |
GHS08 GHS07 Dgr |
3 | View details | ||||||
| Repr. 1B | H360 (H360D) | H360 (H360D) | |||||||||
| STOT RE 2 | H373 (Adrenal glands,...) (oral) | H373 | |||||||||
| STOT RE 2 | H373 (other:Adrenal g...) (oral) | H373 | |||||||||
Number of Aggregated Notifications: 1